The role of MLC901 in reducing VEGF as a vascular permeability marker in rats with spinal cord injury

CONCLUSION: It can be concluded that administration of MLC 901 can reduce vascular permeability, one of the mechanisms that is thought to occur is to reduce VEGF levels. MLC 901 also maintains the neuroprotective effect provided by VEGF by maintaining this level above the basal level until day 14.PMID:35386787 | PMC:PMC8977894 | DOI:10.1016/j.amsu.2022.103344
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research